(Q42833835)

8 November 2017

title

Into the light? Diabetic nephropathy and vitamin D. (English)

1 reference

8 November 2017

0 references

1 reference

Merlin C Thomas

1

1 reference

8 November 2017

Mark E Cooper

series ordinal

2

1 reference

8 November 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

8 November 2017

1 reference

8 November 2017

volume

376

1 reference

8 November 2017

issue

9752

1 reference

8 November 2017

page(s)

1521-1522

1 reference

Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial

8 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961304-9

7 January 2021

Antiproteinuric effect of oral paricalcitol in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961304-9

7 January 2021

Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961304-9

7 January 2021

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961304-9

7 January 2021

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961304-9

7 January 2021

Suppression of renin-angiotensin gene expression in the kidney by paricalcitol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961304-9

7 January 2021

Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961304-9

7 January 2021

The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961304-9

7 January 2021

Microalbuminuria in type 1 diabetes is associated with enhanced excretion of the endocytic multiligand receptors megalin and cubilin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961304-9

7 January 2021

Renoprotective role of the vitamin D receptor in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961304-9

7 January 2021

The impact of diabetes mellitus on vitamin D metabolism in predialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961304-9

7 January 2021

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961304-9

7 January 2021

Mortality risk among hemodialysis patients receiving different vitamin D analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961304-9

7 January 2021

10.1016/S0140-6736(10)61304-9

Identifiers

DOI

1 reference

8 November 2017

1 reference